Literature DB >> 9690982

Lithium and clozapine-induced neutropenia/agranulocytosis.

P Blier1, S Slater, T Measham, M Koch, G Wiviott.   

Abstract

Lithium administration was used in a patient with a clozapine-induced neutropenia and in another with complete agranulocytosis to assess whether lithium could stimulate neutrophil production. In both cases, following lithium administration, the neutrophil count was increased to the normal range within 6 days. In the patient who had presented a neutropenia, clozapine treatment was then reinstated in the presence of lithium and continued without the neutrophil count dropping into the yellow-alert range thereafter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690982     DOI: 10.1097/00004850-199805000-00008

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  12 in total

Review 1.  Continuing clozapine treatment despite neutropenia.

Authors:  David Esposito; Frédéric Rouillon; Frédéric Limosin
Journal:  Eur J Clin Pharmacol       Date:  2004-11-30       Impact factor: 2.953

Review 2.  Continuing clozapine treatment with lithium in schizophrenic patients with neutropenia or leukopenia: brief review of literature with case reports.

Authors:  Memduha Aydin; Bilge Cetin Ilhan; Saliha Calisir; Seda Yildirim; Ibrahim Eren
Journal:  Ther Adv Psychopharmacol       Date:  2016-02

Review 3.  Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.

Authors:  Eromona Whiskey; David Taylor
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

4.  Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".

Authors: 
Journal:  Neuropsychopharmacol Rep       Date:  2021-08-12

Review 5.  Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Authors:  Peter M Haddad; Sonu G Sharma
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Combined clozapine and electroconvulsive therapy in a Japanese schizophrenia patient: a case report.

Authors:  Yuta Yoshino; Yuki Ozaki; Koichiro Kawasoe; Shinichiro Ochi; Takanori Niiya; Naomi Sonobe; Teruhisa Matsumoto; Shu-Ichi Ueno
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-08-12       Impact factor: 2.582

7.  Adjunctive use of lithium carbonate for the management of neutropenia in clozapine-treated children.

Authors:  Anand Mattai; Lawrence Fung; Jennifer Bakalar; Gerald Overman; Julia Tossell; Rachel Miller; Judith Rapoport; Nitin Gogtay
Journal:  Hum Psychopharmacol       Date:  2009-10       Impact factor: 1.672

8.  Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia.

Authors:  Jessica Foster; John Lally; Victoria Bell; Sukhi Shergill
Journal:  BJPsych Open       Date:  2017-02-09

Review 9.  Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.

Authors:  Edward Silva; Melanie Higgins; Barbara Hammer; Paul Stephenson
Journal:  BMC Psychiatry       Date:  2020-06-05       Impact factor: 3.630

10.  Use of lithium in clozapine-induced neutropenia: a case report.

Authors:  Chathurie Suraweera; Raveen Hanwella; Varuni de Silva
Journal:  BMC Res Notes       Date:  2014-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.